11 – 20 of 2282
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Genetic variation at PPM1H predicts mobilization efficiency in stem cell donors
- Contribution to journal › Letter
-
Mark
Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma : a Danish population-based study
- Contribution to journal › Article
-
Mark
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
- Contribution to journal › Scientific review
-
Mark
Contribution of genetics to hematopoietic stem cell mobilization : a genome-wide association study of 564 healthy donors mobilized with granulocyte colony-stimulating factor
- Contribution to journal › Article
-
Mark
Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond
(2025) In Arteriosclerosis, Thrombosis, and Vascular Biology
- Contribution to journal › Scientific review
-
Mark
EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma
- Contribution to journal › Article
-
Mark
Haematological malignancies in systemic sclerosis : a population-based nationwide register study
- Contribution to journal › Article
-
Mark
Metachromatic Leukodystrophy : New Therapy Advancements and Emerging Research Directions
- Contribution to journal › Scientific review
-
Mark
Platelet transfusion practice in the intensive care unit : the Nine-I international platelet transfusion survey
- Contribution to journal › Article
-
Mark
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH) : a randomised, open-label, phase 2/3 superiority trial
- Contribution to journal › Article
